Seroquel XR is an oral psychotropic agent indicated for the treatment of schizophrenia, bipolar disorder and major depressive disorder.
Intellipharmaceutics CEO Isa Odidi said they were very pleased with the FDA’s acceptance of their filing for a generic of Seroquel extended-release capsules.